Researchers have screened thousands of approved drugs against a network of 2,358 longevity-linked genes, producing a shortlist of compounds that may slow biological aging without new drug development.

A model may perform exceptionally well and still lack the evidence package necessary to support regulatory review.

HKeyBio has established HKEY-AI-NAM-Bridge™ 1.0, its AI and New Approach Methodologies (NAMs) In Vivo Evidence Bridging Package. The service helps autoimmune and allergy drug-development teams ...

Celldetective is an open-source software integrating segmentation, tracking, and event detection to perform high-throughput end-to-end study of dynamic cell interactions, without requiring coding ...

An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial ...

Certain gut bacteria may influence the odds of developing MS, in part by altering the activity of specific immune cells, ...

Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...

A framework for analyzing single-cell genomics data, in which geometrical properties are harnessed to obtain insights on cellular diversity, including precise clustering, clear visualizations, and ...

Recent advances in single-cell sequencing and spatial multi-omics have transformed our ability to resolve tumor ecosystems at unprecedented resolution.

Hepatic echinococcosis is a neglected zoonosis caused predominantly by Echinococcus granulosus sensu lato, the agent of cystic echinococcosis (CE), and Echinococcus multilocularis, the agent of ...